BSECompany Update7 Aug 2026 · 7 Aug 2026, 01:44 pm

Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12, 2026

Neuland Laboratories Ltd · 524558

✦ AI SummaryMgmt Change

Neuland Laboratories Ltd has announced a schedule of analyst/institutional investor meetings on August 12, 2026, at Emkay Confluence 2026 in Mumbai.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

adc6a7a8-7303-45c5-8e3e-a0a337794108.pdf

pdf

Download →
View document text
August 7, 2026 BSE Limited The National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, 25th Floor, Exchange Plaza, Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 001 Scrip Code: 524558 Scrip Code: NEULANDLAB; Series: EQ Dear Sir/Madam, Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings This is to inform you that the Company’s management will be participating in the following group analyst/ investor meeting(s): Date Name of the Analyst / Location Nature of the Institutional Investor / Event meeting August 12, 2026 Emkay Confluence 2026 Mumbai Group meet / One-on-One meet Please note that the schedule & participant list of the aforesaid meeting(s) is subject to change due to any exigencies on the part of Participants / Company. This is for your information and records. Thanking you Yours Sincerely, For Neuland Laboratories Limited Sarada Bhamidipati Company Secretary